SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Revelation Biosciences, Inc. REVB NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Revelation Biosciences, Inc. (REVB) 有 12 个已识别的同行可供比较在 Healthcare 板块. 同行包括 BWV, CYTO, HILS, KPRX, NAVB, PHIO 等.

REVB 的市值为 $4.69M, 而同行平均市值为 $35.43M. REVB 显著小于其平均同行.

同行与相似公司 — REVB

Blue Water Vaccines, Inc.

$0.18 -6.97% $3.41M

Altamira Therapeutics Ltd.

$0.30 +100.00% $1.13M

Hillstream BioPharma, Inc.

$0.24 +5.66% $4.17M

Kiora Pharmaceuticals, Inc.

$2.54 +4.10% $10.03M

Navidea Biopharmaceuticals, Inc.

$0.00 0.00% $10.01K

Phio Pharmaceuticals Corp.

$1.32 +2.33% $15.33M

PaxMedica, Inc. Common Stock

$0.00 -54.55% $63.13K

Quoin Pharmaceuticals, Ltd.

$6.49 +3.02% $3.82M

TransCode Therapeutics, Inc.

$8.91 +0.11% $8.17M

Sonnet BioTherapeutics Holdings, Inc.

$1.26 -59.35% $8.43M

Virax Biolabs Group Limited

$0.15 +1.15% $649.99K

Zura Bio Limited

$5.69 -0.52% $369.98M

其他人也在看

Zura Bio Limited

Phio Pharmaceuticals Corp.

Kiora Pharmaceuticals, Inc.

Sonnet BioTherapeutics Holdings, Inc.

TransCode Therapeutics, Inc.

Hillstream BioPharma, Inc.

Quoin Pharmaceuticals, Ltd.

Blue Water Vaccines, Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言